Navigation Links
Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets
Date:7/27/2011

SAN FRANCISCO, July 27, 2011 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter ended June 30, 2011 on Thursday, August 4, 2011, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Friday, September 2, 2011. To access the conference call, follow these instructions:Dial: (877) 299-4454 (U.S.); (617) 597-5447(international)Passcode: 93854703 (Nektar Therapeutics is the host)An audio replay will also be available shortly following the call through Friday, September 2, 2011 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 53256804.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for NKTR-118, an investigational drug can
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
2. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
3. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
4. Nektar to Announce Financial Results for the First Quarter of 2011 on Wednesday, April 27, 2011, After Close of U.S.-Based Financial Markets
5. Nektar Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
6. Nektar Therapeutics President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
7. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
9. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
10. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Array BioPharma,s ... showcased this past weekend at the 2015 ESMO ... presentation.  At the meeting, data were shared from ... a 100-patient randomized Phase 2 expansion of that ... an EGFR inhibitor, with or without the addition ...
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
(Date:7/4/2015)... Añadir micro esferas de ... línea para pacientes con cáncer colorrectal metastásico no ... libre de progresión en ese órgano ... (mCRC) que se ha propagado sólo al hígado ... de progresión (PFS) en el hígado desde la ...
Breaking Medicine Technology:Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5
... 7 AT&T* and eCardio Diagnostics, one of ... announced the combination of mobile technology with cardiac ... heart patients. AT&T is providing eCardio with ... for near real-time, remote monitoring of cardiac patients. ...
... CVS Caremark (NYSE: CVS ) announced ... as Chief Operating Officer of its pharmacy benefit ... President, Rx Purchasing, Pricing and Network Relations, will ... mail service pharmacy and specialty pharmacy. ...
Cached Medicine Technology:AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology 2AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology 3CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer 2
(Date:7/6/2015)... ... July 06, 2015 , ... ... year for aesthetic reasons, which is why liposuction regularly ranks among the top ... however, fat reduction has become more than a way to slim down a ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. ... serious medical conditions. Screenings are affordable and accurate and run about an hour ...
(Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and fastest-growing urgent care ... urgent care center will serve residents and visitors in the Cutler Bay area, giving ... 22nd South Florida location, the new facility will be the fourth to serve Miami-Dade ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering ... Kybella is a non-surgical method to dissolve fat cells and is the ... severe fat deposits under the chin, commonly known as a double chin. Dr. Green ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Path of Least Resistance: The Evolution of ... with the U.S. economy over the past 40 years. The book explores the evolution ... ways, the book is a time capsule that chronicles the economic development of the ...
Breaking Medicine News(10 mins):Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2
... PRINCETON, N.J., Aug. 24 Ranbaxy Pharmaceuticals Inc. (RPI), ... today that RLL has received approval from the U.S. Food ... 1 mg and 2 mg. The Office of Generic ... formulations to be bioequivalent and have the same therapeutic effect ...
... , , ATLANTA, Aug. 24 ... by the American Diabetes Association (ADA), kicks off in Atlanta on ... F earless A frican-Americans C onnected and E ... also supported by Aetna, educates and empowers African-Americans living with diabetes ...
... , , SKILLMAN, N.J., Aug. ... community and hospital care, today announced new data showing that AQUACEL(R) ... an MRI environment. , , AQUACEL(R) Ag dressing ... gelling benefits of ConvaTec,s proprietary Hydrofiber(R) Technology plus the ...
... International Journal of Obesity reports that consumption of ... a key aspect of successful weight maintenance. ... intake, as well as the dietary restraint of over ... use of artificially sweetened beverages may be an important ...
... enough, experts warn , MONDAY, Aug. 24 (HealthDay News) -- ... virus if they believe the risks outweigh the benefits, suggests ... in Vancouver before the start of the current swine flu ... a new vaccine in the event of a pandemic. , ...
... , SAN ANTONIO, Aug. 24 Fall 2009 ... family schedules, which can have a devastating impact on family pets that ... PurinaCare(R) Pet Health Insurance ( www.purinacare.com ), which is committed to help ... all pet owners to be aware of the signs of post-summer ...
Cached Medicine News:Health News:Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 2Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 2Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 3Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 4Health News:New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing 2Health News:New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing 3Health News:New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing 4Health News:New research: Consumption of sugar substitutes assists in long-term weight control 2Health News:Not Everyone Wants to Be Vaccinated Against Pandemic Flu 2Health News:Does Your Pet Have Post-Summer Separation Anxiety? 2Health News:Does Your Pet Have Post-Summer Separation Anxiety? 3
Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Straight shafts with 1 x 2 Elsching style teeth. Wide serrated handle with polished finish....
Straight crisscross serrated tips. Flat handle with holes and polished finish....
Medicine Products: